FDA Announces Draft Guidance for Bioequivalence of Additional Strengths of Immediate-Release Oral Dosage Forms

Summary

The FDA has released a draft guidance on bioequivalence for additional strengths of immediate-release oral dosage forms, prepared by the International Council for Harmonisation, with the goal of providing harmonized criteria for drug applications with multiple strengths.